权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife

先兆子痫和大脑：中年早期的小血管疾病和认知功能

基本信息

批准号：
10552017
负责人：
Janet M Catov
金额：
$ 103.37万
依托单位：
MAGEE-WOMEN'S RES INST AND FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-02-01 至 2026-11-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10552017
关键词：
Acute Affect Age Alzheimer&apos s Disease Apolipoprotein E Area Beds Benefits and Risks Bioinformatics Biological Markers Blood Blood Vessels Blood flow Brain Cardiac Cardiovascular system Cerebral small vessel disease Cerebrovascular Circulation Cerebrum Chronic Clinical Trials Cognition Cognitive Data Dementia Diffusion Magnetic Resonance Imaging Disease Disease Progression Early Intervention Endoglin Enrollment Epidemiology Etiology Exposure to Future Genotype Health Hypertension Hypoxia Impaired cognition Inflammation Life Life Style Machine Learning Measures Microvascular Dysfunction Monitor Neurocognitive Neurologic Outcome Pathology Patient Self-Report Phenotype Pilot Projects Placenta Positioning Attribute Pre-Eclampsia Pregnancy Pregnancy Outcome Prevention Probability Process Protocols documentation Race Recording of previous events Reperfusion Injury Rest Risk Risk Assessment Risk Factors Risk Management Spiral Artery of the Endometrium Standardization Techniques Testing Time White Matter Hyperintensity Woman angiogenesis blood-based biomarker cardiometabolism cardiovascular risk factor cerebrovascular circulating biomarkers cognitive function cognitive performance cohort dementia risk executive function gray matter high risk population human old age (65+)information processing middle age multidisciplinary multimodal neuroimaging neural neuroimaging older women post pregnancy primary outcome processing speed racial diversity risk stratification sex statistics vascular bed vascular cognitive impairment and dementia young woman

项目摘要

Cerebral small vessel disease (cSVD) predisposes to vascular cognitive impairment and dementia, including Alzheimer’s Disease. Preeclampsia (PE), a pregnancy-specific disorder with acute hypertension and placental SVD, is emerging as a sex-specific risk factor for dementia later in life. How PE is implicated in the etiology of dementia is not known. Women with PE have SVD also in other vascular beds, including the brain, after pregnancy and worsening with older age, suggesting this process evolves over time. However, studies on SVD in midlife are sparse. Midlife is an ideal time to assess this risk as PE-differences in cognition are already detectable, and yet there is time to mitigate progression to dementia. Cerebral SVD (cSVD) in midlife may hold the key to understand how PE is implicated in cognitive impairment. Placental SVD, known as maternal vascular malperfusion (MVM) predicts worse short-term pregnancy outcomes. We find MVM and PE combined predict long-term worse maternal vascular health in cardiac, sublingual, and cerebral beds. In our pilot study (n=24) MVM and PE combined predicted lower cerebrovascular reactivity (CVR, an early stage of cSVD), especially in fronto-parietal areas; in turn, lower CVR in these regions was associated with, and appeared to explain, PE-related worse cognition. Importantly, these findings were independent of hypertension, suggesting PE has direct and lasting vascular effects . PE and MVM may be early indicators of a future cerebrovascular phenotype, manifesting in midlife as lower CVR, and may explain how PE affects cognition. We propose to study midlife women with and without prior PE to: 1) Characterize the neural basis of PE-related poorer cognitive performance, 2) Assess whether placental SVD (MVM) predicts cSVD and cognition, and 3) Explore whether sublingual SVD and circulating markers of SVD are markers of cSVD and cognition. We propose a neurocognitive study to capture early stages of cSVD and cognitive status in a racially diverse cohort of 450 women (1:1 PE and non PE) from our ongoing WINDOWS study, mean age=45, 15 years post- pregnancy, 30% black, with existing data on PE, MVM, and sublingual SVD 10 years after pregnancy. We will use our advanced multimodal neuroimaging protocols to quantify cSVD (including CVR, blood flow, connectivity), standardized validated protocols to measure cognition, and non-invasive markers of SVD (sublingual SVD, and circulating biomarker profiles) . Our project is uniquely positioned to identify a previously occult high-risk group that can be identified at delivery by placental pathology, and who may benefit from risk- stratification for dementia, to mitigate or delay disease progression.

脑血管病（cSVD）易导致血管性认知障碍和痴呆，包括